Evonik Evonik

X

CAS 152460-09-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 152460-09-8
Also known as: 152460-09-8, N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidine-amine, N-(2-methyl-5-nitrophenyl)-4-pyridin-3-ylpyrimidin-2-amine, N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidineamine, Chembl20426, 2-methyl-5-nitro-n-[4-(pyridin-3-yl)pyrimidin-2-yl]benzenamine
Molecular Formula
C16H13N5O2
Molecular Weight
307.31  g/mol
InChI Key
OJITWRFPRCHSMX-UHFFFAOYSA-N

1 2D Structure

CAS 152460-09-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(2-methyl-5-nitrophenyl)-4-pyridin-3-ylpyrimidin-2-amine
2.1.2 InChI
InChI=1S/C16H13N5O2/c1-11-4-5-13(21(22)23)9-15(11)20-16-18-8-6-14(19-16)12-3-2-7-17-10-12/h2-10H,1H3,(H,18,19,20)
2.1.3 InChI Key
OJITWRFPRCHSMX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C=C(C=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN=CC=C3
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 152460-09-8

2. N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidine-amine

3. N-(2-methyl-5-nitrophenyl)-4-pyridin-3-ylpyrimidin-2-amine

4. N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidineamine

5. Chembl20426

6. 2-methyl-5-nitro-n-[4-(pyridin-3-yl)pyrimidin-2-yl]benzenamine

7. 2-pyrimidinamine, N-(2-methyl-5-nitrophenyl)-4-(3-pyridinyl)-

8. (2-methyl-4-nitro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine

9. N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidinamine

10. Imatinib Related Compound

11. Schembl1550

12. Schembl13597737

13. Dtxsid50443544

14. Act04899

15. Bcp12559

16. Bdbm50287093

17. Mfcd02179269

18. Vcc987289

19. Zinc21298122

20. Akos015909809

21. Ac-2148

22. Sb58381

23. 112gi008

24. Ds-14539

25. Am20050826

26. Cs-0153572

27. Ft-0654432

28. M2584

29. Vu0549313-1

30. 460m098

31. A809314

32. J-008922

33. 2-(2-methyl-5-nitroanilino)-4-(3-pyridinyl)pyrimidine

34. F9995-0184

35. N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-pyrimidine-amine

36. N-(5-nitro-2-methylphenyl)-4-(3-pyridinyl)-2-pyrimidineamine

37. (2-methyl-5-nitro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine

38. N-(2-methyl-5-nitrophenyl)-4- (pyridin-3-yl)pyrimidin-2-amine

39. N-(2-methyl-5-nitrophenyl)-4-(3-pyridinyl)-2 Pyrimidine Amine

40. N-(2-methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-pyrimidine Amine

41. N-(2-methyl-5-nitro-phenyl)-4-(3-pyridyl)pyrimidin-2-amine;n-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 307.31 g/mol
Molecular Formula C16H13N5O2
XLogP32.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass307.10692467 g/mol
Monoisotopic Mass307.10692467 g/mol
Topological Polar Surface Area96.5 Ų
Heavy Atom Count23
Formal Charge0
Complexity402
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
55314-16-4
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
350-03-8
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
152460-10-1
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
106261-49-8
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY